Related Experiment Videos

Apoptosis in atherosclerosis: beneficial or detrimental?

M M Kockx1, A G Herman

  • 1Department of Pathology, A.Z. Middelheim, Antwerp, Belgium. mark.kockx@uia.ua.ac.be

Insights

Apoptosis, or programmed cell death, in atherosclerosis is detrimental, potentially causing plaque rupture and thrombosis. Lipid lowering therapies may reduce this cell death, aiding plaque stabilization.

Area of Science:

  • Cardiovascular Biology
  • Cellular Pathology

Background:

  • Apoptotic cell death occurs in atherosclerotic plaques, involving macrophages and smooth muscle cells.
  • The role of apoptosis in atherosclerosis varies with plaque stage, location, and cell type.

Purpose of the Study:

  • To investigate the significance of apoptotic cell death in atherosclerotic plaque stability.
  • To explore the impact of lipid-lowering on apoptosis within atherosclerotic plaques.

Main Methods:

  • Analysis of apoptotic cell death in atherosclerotic plaques.
  • Correlation of apoptosis with DNA synthesis/repair and plaque characteristics.
  • Evaluation of apoptosis changes following lipid-lowering interventions.

Main Results:

  • Smooth muscle cell apoptosis occurs in less cellular regions and is not linked to DNA repair.
  • Macrophage apoptosis is associated with DNA synthesis/repair.
  • Unscavenged apoptotic cells can activate thrombin, promoting thrombosis.
  • Apoptosis decreases following lipid-lowering therapy.

Conclusions:

  • Apoptosis in atherosclerosis is generally detrimental, potentially leading to plaque rupture and thrombosis.
  • Smooth muscle cell loss due to apoptosis compromises plaque stability.
  • Effective clearance of apoptotic bodies may be crucial for plaque stability.
  • Lipid-lowering interventions show potential in stabilizing atherosclerotic plaques by reducing apoptosis.

Related Concept Videos